Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers – The filing reports executive or board-level personnel changes and/or compensation-related matters as of January 16, 2026 Item 9.01: Financial Statements and Exhibits – The filing includes exhibits related to the reported events, though…

Our analysis rates this filing BULLISH. This 8-K filing documents a routine executive compensation arrangement with no material business concerns. The risk score of 2.1 and STABLE trend reflect normal operational governance. While the compensation package is elevated, it is transparently disclosed,…

Concern level: MODERATE (2.1/10). Key factors: Executive compensation cost increase: Adam Ray's annual equity grant increased to $4.25M plus $500K top-up, representing elevated but disclosed executive retention costs; Severance package of approximately $3.6M+ (2.0x multiplier on base + target bonus) creates contingent liability, though standard for C-suite executives; Two-year non-compete…

Notable risk changes: Executive Vice President, Chief Commercial Officer (Adam Ray) entered into new 2-year employment agreement effective January 19, 2026, replacing prior agreement from January 2024; Severance package provides 2.0x multiplier on base salary plus target bonus (approximately $3.6M+ based on disclosed compensation), plus 24 months COBRA and outplacement services; Annual equity awards increased to…

The model predicts CHTR will outperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.